|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online September 12, 2003
doi: 10.1242/10.1242/jcs.00739
Commentary |
1 Department of Pharmacy, The Hebrew University Hadassah Medical School, Jerusalem 91120, Israel
2 Lautenberg Center for General and Tumor Immunology, The Hebrew University Hadassah Medical School, Jerusalem 91120, Israel
* Author for correspondence (e-mail: haupt{at}md.huji.ac.il)
Exposure to cellular stress can trigger the p53 tumor suppressor, a sequence-specific transcription factor, to induce cell growth arrest or apoptosis. The choice between these cellular responses is influenced by many factors, including the type of cell and stress, and the action of p53 co-activators. p53 stimulates a wide network of signals that act through two major apoptotic pathways. The extrinsic, death receptor pathway triggers the activation of a caspase cascade, and the intrinsic, mitochondrial pathway shifts the balance in the Bcl-2 family towards the pro-apoptotic members, promoting the formation of the apoptosome, and consequently caspase-mediated apoptosis. The impact of these two apoptotic pathways may be enhanced when they converge through Bid, which is a p53 target. The majority of these apoptotic effects are mediated through the induction of specific apoptotic target genes. However, p53 can also promote apoptosis by a transcription-independent mechanism under certain conditions. Thus, a multitude of mechanisms are employed by p53 to ensure efficient induction of apoptosis in a stage-, tissue- and stress-signal-specific manner. Manipulation of the apoptotic functions of p53 constitutes an attractive target for cancer therapy.
Key words: p53, Apoptosis, Caspase, Mitochondria, Transcriptional activation
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
A.-C. Tsai, S.-L. Pan, H.-L. Sun, C.-Y. Wang, C.-Y. Peng, S.-W. Wang, Y.-L. Chang, S.-C. Kuo, K.-H. Lee, and C.-M. Teng CHM-1, a New Vascular Targeting Agent, Induces Apoptosis of Human Umbilical Vein Endothelial Cells via p53-mediated Death Receptor 5 Up-regulation J. Biol. Chem., February 19, 2010; 285(8): 5497 - 5506. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Nakamura, J. H. Do, J. Yuan, I. V. Odinokova, O. Mareninova, A. S. Gukovskaya, and S. J. Pandol Inflammatory cells regulate p53 and caspases in acute pancreatitis Am J Physiol Gastrointest Liver Physiol, January 1, 2010; 298(1): G92 - G100. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li, L.-J. Li, S.-T. Zhang, L.-J. Wang, Z. Zhang, N. Gao, Y.-Y. Zhang, and Q.-M. Chen In vitro and Clinical Studies of Gene Therapy with Recombinant Human Adenovirus-p53 Injection for Oral Leukoplakia Clin. Cancer Res., November 1, 2009; 15(21): 6724 - 6731. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-M. Lee, J.-H. Lim, Y.-S. Chun, H.-E. Moon, M. K. Lee, L.E. Huang, and J.-W. Park Nutlin-3, an Hdm2 antagonist, inhibits tumor adaptation to hypoxia by stimulating the FIH-mediated inactivation of HIF-1{alpha} Carcinogenesis, October 1, 2009; 30(10): 1768 - 1775. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-Y. Chien, Y.-C. Wu, J.-G. Chung, J.-S. Yang, H.-F. Lu, M.-F. Tsou, W. Wood, S.-J. Kuo, and D.-R. Chen Quercetin-induced apoptosis acts through mitochondrial- and caspase-3-dependent pathways in human breast cancer MDA-MB-231 cells Human and Experimental Toxicology, August 1, 2009; 28(8): 493 - 503. [Abstract] [PDF] |
||||
![]() |
O. K. Leong, T. S. T. Muhammad, and S. F. Sulaiman Cytotoxic Activities of Physalis minima L. Chloroform Extract on Human Lung Adenocarcinoma NCI-H23 Cell Lines by Induction of Apoptosis Evid. Based Complement. Altern. Med., June 18, 2009; (2009) nep057v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kleinridders, H.-M. Pogoda, S. Irlenbusch, N. Smyth, C. Koncz, M. Hammerschmidt, and J. C. Bruning PLRG1 Is an Essential Regulator of Cell Proliferation and Apoptosis during Vertebrate Development and Tissue Homeostasis Mol. Cell. Biol., June 1, 2009; 29(11): 3173 - 3185. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ahn, I.-J. L. Byeon, C.-H. Byeon, and A. M. Gronenborn Insight into the Structural Basis of Pro- and Antiapoptotic p53 Modulation by ASPP Proteins J. Biol. Chem., May 15, 2009; 284(20): 13812 - 13822. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Sa, T. Das, C. Moon, C. M. Hilston, P. A. Rayman, B. I. Rini, C. S. Tannenbaum, and J. H. Finke GD3, an Overexpressed Tumor-Derived Ganglioside, Mediates the Apoptosis of Activated but not Resting T Cells Cancer Res., April 1, 2009; 69(7): 3095 - 3104. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lim, A. C. Hung, and A. G. Porter Focused PCR Screen Reveals p53 Dependence of Nitric Oxide-Induced Apoptosis and Up-Regulation of Maspin and Plasminogen Activator Inhibitor-1 in Tumor Cells Mol. Cancer Res., January 1, 2009; 7(1): 55 - 66. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. K. Hoffmann, I. H. Lambert, and S. F. Pedersen Physiology of Cell Volume Regulation in Vertebrates Physiol Rev, January 1, 2009; 89(1): 193 - 277. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hu, H.-J. Lee, C. Jiang, J. Zhang, L. Wang, Y. Zhao, Q. Xiang, E.-O. Lee, S.-H. Kim, and J. Lu Penta-1,2,3,4,6-O-galloyl-{beta}-D-glucose induces p53 and inhibits STAT3 in prostate cancer cells in vitro and suppresses prostate xenograft tumor growth in vivo Mol. Cancer Ther., September 1, 2008; 7(9): 2681 - 2691. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Shetty, S. H. Shao, and C. C. Y. Weng p53-Dependent Apoptosis in the Inhibition of Spermatogonial Differentiation in Juvenile Spermatogonial Depletion (Utp14bjsd) Mice Endocrinology, June 1, 2008; 149(6): 2773 - 2781. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Fini, E. Hotchkiss, V. Fogliano, G. Graziani, M. Romano, E. B. De Vol, H. Qin, M. Selgrad, C.R. Boland, and L. Ricciardiello Chemopreventive properties of pinoresinol-rich olive oil involve a selective activation of the ATM-p53 cascade in colon cancer cell lines Carcinogenesis, January 1, 2008; 29(1): 139 - 146. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Poeta, J. Manola, M. A. Goldwasser, A. Forastiere, N. Benoit, J. A. Califano, J. A. Ridge, J. Goodwin, D. Kenady, J. Saunders, et al. TP53 Mutations and Survival in Squamous-Cell Carcinoma of the Head and Neck N. Engl. J. Med., December 20, 2007; 357(25): 2552 - 2561. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Amaral, R. E. Castro, S. Sola, C. J. Steer, and C. M. P. Rodrigues p53 Is a Key Molecular Target of Ursodeoxycholic Acid in Regulating Apoptosis J. Biol. Chem., November 23, 2007; 282(47): 34250 - 34259. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-K. Youn, P. I. Song, M.-H. Kim, J. S. Kim, J.-W. Hyun, S.-J. Choi, S. P. Yoon, M. H. Chung, I.-Y. Chang, and H. J. You Human 8-Oxoguanine DNA Glycosylase Suppresses the Oxidative Stress Induced Apoptosis through a p53-Mediated Signaling Pathway in Human Fibroblasts Mol. Cancer Res., October 1, 2007; 5(10): 1083 - 1098. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Chen, Z. Hu, L.-E Wang, W. Zhang, A. K. El-Naggar, E. M. Sturgis, and Q. Wei Polymorphic TP53BP1 and TP53 Gene Interactions Associated with Risk of Squamous Cell Carcinoma of the Head and Neck Clin. Cancer Res., July 15, 2007; 13(14): 4300 - 4305. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. B. Nguyen, I. V. Subramanian, A. Kelekar, and S. Ramakrishnan Kringle 5 of human plasminogen, an angiogenesis inhibitor, induces both autophagy and apoptotic death in endothelial cells Blood, June 1, 2007; 109(11): 4793 - 4802. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W.P. Wijnhoven, E. N. Speksnijder, X. Liu, E. Zwart, C. Th. M. vanOostrom, R. B. Beems, E. M. Hoogervorst, M. M. Schaap, L. D. Attardi, T. Jacks, et al. Dominant-Negative but not Gain-of-Function Effects of a p53.R270H Mutation in Mouse Epithelium Tissue after DNA Damage Cancer Res., May 15, 2007; 67(10): 4648 - 4656. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Fabian, C. M. Csatary, J. Szeberenyi, and L. K. Csatary p53-Independent Endoplasmic Reticulum Stress-Mediated Cytotoxicity of a Newcastle Disease Virus Strain in Tumor Cell Lines J. Virol., March 15, 2007; 81(6): 2817 - 2830. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Kroemer, L. Galluzzi, and C. Brenner Mitochondrial Membrane Permeabilization in Cell Death Physiol Rev, January 1, 2007; 87(1): 99 - 163. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Bonofiglio, S. Aquila, S. Catalano, S. Gabriele, M. Belmonte, E. Middea, H. Qi, C. Morelli, M. Gentile, M. Maggiolini, et al. Peroxisome Proliferator-Activated Receptor-{gamma} Activates p53 Gene Promoter Binding to the Nuclear Factor-{kappa}B Sequence in Human MCF7 Breast Cancer Cells Mol. Endocrinol., December 1, 2006; 20(12): 3083 - 3092. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wirtenberger, B. Frank, K. Hemminki, R. Klaes, R. K. Schmutzler, B. Wappenschmidt, A. Meindl, M. Kiechle, N. Arnold, B. H.F. Weber, et al. Interaction of Werner and Bloom syndrome genes with p53 in familial breast cancer Carcinogenesis, August 1, 2006; 27(8): 1655 - 1660. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yim, I. S. Hwang, J.-S. Choi, K.-H. Chun, Y. H. Jin, Y.-M. Ham, K. Y. Lee, and S. K. Lee Cleavage of Cdc6 by caspase-3 promotes ATM/ATR kinase-mediated apoptosis of HeLa cells J. Cell Biol., July 3, 2006; 174(1): 77 - 88. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. N. Keswani, A. Noffsinger, I. Waxman, and M. Bissonnette Clinical Use of p53 in Barrett's Esophagus. Cancer Epidemiol. Biomarkers Prev., July 1, 2006; 15(7): 1243 - 1249. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. R. Rezvani, F. Mazurier, M. Cario-Andre, C. Pain, C. Ged, A. Taieb, and H. de Verneuil Protective Effects of Catalase Overexpression on UVB-induced Apoptosis in Normal Human Keratinocytes J. Biol. Chem., June 30, 2006; 281(26): 17999 - 18007. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lacroix, R.-A. Toillon, and G. Leclercq p53 and breast cancer, an update. Endocr. Relat. Cancer, June 1, 2006; 13(2): 293 - 325. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Todorovicc, C.-C. Chen, N. Hay, and L. F. Lau The matrix protein CCN1 (CYR61) induces apoptosis in fibroblasts J. Cell Biol., November 7, 2005; 171(3): 559 - 568. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Mandic, C. J. Schamberger, J. F. Muller, M. Geyer, L. Zhu, T. E. Carey, R. Grenman, A. A. Dunne, and J. A. Werner Reduced Cisplatin Sensitivity of Head and Neck Squamous Cell Carcinoma Cell Lines Correlates with Mutations Affecting the COOH-Terminal Nuclear Localization Signal of p53 Clin. Cancer Res., October 1, 2005; 11(19): 6845 - 6852. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-R. Zhou, Z. Islam, and J. J. Pestka Induction of Competing Apoptotic and Survival Signaling Pathways in the Macrophage by the Ribotoxic Trichothecene Deoxynivalenol Toxicol. Sci., September 1, 2005; 87(1): 113 - 122. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Strauss, K. Kelly, and D. Ekiert Cytochrome Oxidase Deficiency Protects Escherichia coli from Cell Death but Not from Filamentation Due to Thymine Deficiency or DNA Polymerase Inactivation J. Bacteriol., April 15, 2005; 187(8): 2827 - 2835. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Johnson, E. M. Shepard, and K. W. Scotto Differential Regulation of MDR1 Transcription by the p53 Family Members: ROLE OF THE DNA BINDING DOMAIN J. Biol. Chem., April 8, 2005; 280(14): 13213 - 13219. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lucken-Ardjomande and J.-C. Martinou Newcomers in the process of mitochondrial permeabilization J. Cell Sci., February 1, 2005; 118(3): 473 - 483. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wesierska-Gadek, M. Gueorguieva, and M. Horky Roscovitine-induced up-regulation of p53AIP1 protein precedes the onset of apoptosis in human MCF-7 breast cancer cells Mol. Cancer Ther., January 1, 2005; 4(1): 113 - 124. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Liu, D. P. Thewke, Y. R. Su, M. F. Linton, S. Fazio, and M. S. Sinensky Reduced Macrophage Apoptosis Is Associated With Accelerated Atherosclerosis in Low-Density Lipoprotein Receptor-Null Mice Arterioscler Thromb Vasc Biol, January 1, 2005; 25(1): 174 - 179. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Gourmelon, C Marquette, D Agay, J Mathieu, and D Clarencon Involvement of the central nervous system in radiation-induced multi-organ dysfunction and/or failure Br. J. Radiol., January 1, 2005; Supplement_27(1): 62 - 68. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Scheckenbach, O. Lieven, K. Gotte, U. Bockmuhl, R. Zotz, H. Bier, and V. Balz p53 Codon 72 Polymorphic Variants, Loss of Allele-Specific Transcription, and Human Papilloma Virus 16 and/or 18 E6 Messenger RNA Expression in Squamous Cell Carcinomas of the Head and Neck Cancer Epidemiol. Biomarkers Prev., November 1, 2004; 13(11): 1805 - 1809. [Abstract] [Full Text] [PDF] |
||||